Autoimmune disease

#Autoimmune disease #Breast cancer #Cancer immunotherapy #Clinical trials #Immunotherapy #LAG-3

Phase II/III trial to assess LAG-3 immunotherapy in breast cancer 

Immutep, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, has initiated AIPAC-003 (Active Immunotherapy, Eftilagimod Alpha, and Paclitaxel), an integrated Phase II/III trial to evaluate eftilagimod alpha (efti) in combination with paclitaxel for the treatment of metastatic HER2-neg/low breast cancer (MBC).  … Read More

#News

Artificial sweetener
#Animal models #Autoimmune disease #Francis Crick Institute #Immune response #T cell activation

Artificial sweetener dampened T cell response in mice

Scientists at the Francis Crick Institute have found that high consumption of a common artificial sweetener, sucralose, lowers activation of T cells in mice. If found to have similar effects in humans, one day it could be used therapeutically to help dampen T cell responses. For… Read More

#News

#Autoimmune disease #Biopharmaceuticals #Covid-19 #Long Covid #Multiple sclerosis #Neurodegenerative disorders

€25 million to support clinical developments against long Covid

GeNeuro, a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe consequences of Covid-19, (PASC, post-Covid or long Covid), has entered into a credit agreement for a total amount of up to €25 million with the… Read More

#News

#Autoimmune disease #Cancer research #Clinical trial #Fibrosis #Immunotherapy #Oncology

First-line clinical trial marks a turning point in drug development 

Genoscience Pharma, a clinical-stage biotech company developing lysosomotropic drug candidates for the treatment of cancer, fibrosis and auto-immune diseases through autophagy modulation has launched the ABE-LIVER study, along with trial sponsor Grenoble University Hospital.  The trial   This Phase IIb clinical trial will focus on first-line… Read More

#Cancer Research #News

CAR-T therapy
#Autoimmune disease #Cancer #CAR-T #Immunotherapy #Mouse models

CAR-T therapy successfully used to treat autoimmune disease

CAR-T therapy can be used to eliminate unwanted cells that cause autoimmunity, according to the results of a new study in mice with an autoimmune disease similar to multiple sclerosis (MS).  CAR-T, which uses genetically altered immune cells to destroy cancer cells, has revolutionised treatment of some… Read More

#News #Trending News

Arsenic Trioxide
#Anti-inflammatory #Arsenic Trioxide #Autoimmune disease #Graft vs Host Disease #Phase II trial #Stem cell transplant #Transplant

Phase II success for autoimmune disease platform in GVHD

BioSenic’s arsenic trioxide (ATO) autoimmune disease platform has completed a successful Phase IIb trial in chronic Graft vs Host Disease (cGVHD) and is preparing to move to a Phase III trial.  The BioSenic autoimmune platform was created by Medsenic to target systemic autoimmune diseases using ATO as… Read More

#News

Human kidneys
#Autoimmune disease #European Commission #Human trials #Lupus

EU approval for first oral treatment for lupus nephritis

Otsuka Pharmaceutical’s Lupkynis (voclosporin) is the first oral treatment to be approved in Europe for the treatment of active lupus nephritis (LN) in adult patients. The drug has received approval from the European Commission (EC) in combination with mycophenolate mofetil (MMF) for the treatment of adult patients with active class… Read More

#News #Regulatory

Diabetes patient injecting insulin
#Autoimmune disease #Biomedical research #Cardiovascular disease #Diabetes #Statins #Type 2 diabetes

Study: autoimmune disorders increase cardiovascular risk

Individuals with an autoimmune disorder have a substantially higher risk of developing cardiovascular disease, a large epidemiological study has revealed.  The research – led by KU Leuven in collaboration with colleagues in the UK, including the University of Glasgow, and published in The Lancet – shows for the first… Read More

#News

#Autoimmune disease #Diabetes #Drug discovery

Australian discovery boosts hopes of preventing Type 1 diabetes

Australian researchers based may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could prevent the autoimmune disease from taking hold. Mater Research and University of Queensland researchers have developed a biological agent, sRAGE, that boosts white blood cell function which is damaged in… Read More

#Editor's Choice #News #Trending News

#Antibody #Autoimmune disease

Immutep granted Japanese patent for immunosuppressive antibody  

Biotechnology company Immutep has been a granted a patent for its immunosuppressive antibody by the Japanese Patent Office.  Immutep’s IMP761 is an immunosuppressive agonist antibody to LAG-3 – a cell surface molecule which plays a role in regulating T cell function, and which has been identified as… Read More

#News

A woman scratching her skin
#Autoimmune disease #Digital therapeutics

Sidekick Health launches digital platform for atopic dermatitis  

Digital therapeutics provider Sidekick Health has launched an integrated solution for improving the outcomes of patients with Atopic Dermatitis (AD). The product was developed in collaboration with Pfizer and will be rolled out in the UK first before being launched in other regions.   The launch marks the… Read More

#News

#Autoimmune disease #Immunology #Pharma

Understanding and innovating in immunology

Listen to this article on the DDW Podcast: Chiedzo Mpofu, Vice President, Global Medical Affairs Head, Immunology, at AbbVie, talks to Lu Rahman about our understanding of auto-immune disease and how AbbVie is continuing to innovate in this field. “Immune mediated diseases are a diverse group of conditions that… Read More

#Exclusive Content

#Autoimmune disease #iPSC #Stem cells

New human beta cell model enables discoveries in diabetes research 

Human Cell Design, a biotechnology company focused on generating translational human cellular models, has launched Endoc-BH5 to “open up entirely new scientific avenues in diabetes studies”, the company says.   What is Endoc-BH5?  Human Cell Design combined hiPSC-derived differentiated cells (human-induced Pluripotent Stem Cells) and primary… Read More

#News

#Autoimmune disease #Drug discovery #Research

Study profiles side-effects linked to common immunosuppressant 

New research led by scientists from the UK’s University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) has profiled the side effects of methotrexate – a common drug used to treat arthritis and other autoimmune diseases.   The findings  The authors hope their findings –… Read More

#News

#Antibodies #Autoimmune disease #Clinical trials #Therapeutics

eBook: Antibody production

In immunoassays-based research, immunodiagnostics, as well as immunotherapy, one of the highly critical aspect of antibodies is their reproducible performance. Antibody reproducibility is driven by their specificity and several other factors ranging from antibody design to target validation. This NEW eBook Antibody Production gives you an overview of the… Read More

#News

#Autoimmune disease #Biology #Drug development #Drug discovery #Research study #Therapeutics

Human-on-a-Chip approach validated to model rare autoimmune disease

A new peer-reviewed article demonstrated that Hesperos’ Human-on-a-Chip (HoaC) cell-based neuromuscular junction (NMJ) platform system can mimic the disease phenotypes of myasthenia gravis (MG). The manuscript, titled “A Functional Human-on-a-Chip Autoimmune Disease Model of Myasthenia Gravis for Development of Therapeutics,” was published in Frontiers in Cell and Developmental Biology. Read More

#News